JUN 16, 2021 7:00 AM PDT

The paradigm of lung cancer: from therapy selection to resistance monitoring

Sponsored by: Agilent
Speaker
  • Full Professor of Pathology and Director of the Inter-Departmental Center of Advanced Molecular Diagnostics and Innovative Therapies, University of Chieti-Pescara, Italy
    BIOGRAPHY

Abstract
Date:  June 16, 2021
Time: 7:00am (PDT),  10:00am (EDT)
 
Non-small cell lung cancer (NSCLC) has become an important example of precision medicine among solid tumor malignancies. Next-generation sequencing panels have proven to be powerful tools for multi-marker analysis and here, we describe the use of an all-in one lung panel to detect mutations in lung tumor samples. In addition, we have been able to identify specific mutations in liquid biopsies—such as CNVs and gene fusions—that are important drivers of resistance in NSCLC.
 
Learning Objectives
  • Explain how lung cancer treatment has changed in the context of personalized medicine
  • Describe the approach of detecting DNA fusions using the SureSelect hybrid capture-based targeted NGS
  • Share experience in implementing an automated NGS workflow with the Magnis NGS Prep System and SureSelect Cancer All-In-One panels

 

For Research Use Only. Not for use in diagnostic procedures.
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
JUN 28, 2022 6:45 AM PDT
JUN 28, 2022 6:45 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
Loading Comments...
Show Resources